MedTrace Logo

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

NCT00150098 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2014-04-08

No results posted yet for this study

Summary

To determine the efficacy of an enhanced HIV risk reduction intervention delivered concurrently with a vaccination schedule to reduce the number of unprotected vaginal and anal sex acts among HIV-negative, high-risk non-injection drug-using (NIDU) women. To determine the efficacy of an enhanced vaccine education intervention delivered at baseline to increase vaccine knowledge and understanding of a potential HIV vaccine among HIV-negative, high-risk NIDU women.

Conditions

Interventions

BEHAVIORAL

Enhanced HIV risk reduction and HIV vaccine education

Sponsors & Collaborators

  • The New York Academy of Medicine

    collaborator OTHER

  • Rutgers University

    collaborator OTHER

  • New York Blood Center

    lead OTHER

Principal Investigators

  • Beryl A Koblin, Ph.D. · New York Blood Center

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-02-28
Primary Completion
2009-11-30
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00150098 on ClinicalTrials.gov